Pediatric specialists are urging parents to prioritize RSV immunization for newborns to protect infants against severe respiratory infections during peak virus season. According to Dr. Jill Maron, pediatrician-in-chief at Women & Infants Hospital, preventive antibody shots offer crucial defense for newborns whose immune systems are still developing.
Understanding RSV Risks in Newborns
Respiratory syncytial virus (RSV) remains a leading cause of hospitalization among infants under one year old. According to the Centers for Disease Control and Prevention, the virus causes inflammation in the small airways of the lungs, leading to conditions like bronchiolitis and pneumonia. Newborns face the highest risk for severe complications because their airways are small and easily obstructed by mucus and swelling.
Clinical data shows that infants born during or entering their first RSV season benefit significantly from monoclonal antibody protection. Unlike traditional vaccines that train the immune system over time, monoclonal antibodies provide immediate, passive immunity. This defense helps reduce the severity of illness and lowers the likelihood of emergency room visits or pediatric intensive care unit admissions.
Immunization Options and Timing
Medical providers recommend administering the RSV immunization, such as nirsevimab, to infants entering their first respiratory virus season. According to the American Academy of Pediatrics, the ideal window for administration is shortly before or during the RSV season, which typically runs from fall through spring.
- Nirsevimab (Beyfortus): A long-acting monoclonal antibody given as a single injection to newborns and infants under eight months entering their first RSV season.
- Maternal RSV Vaccine (Abrysvo): Administered to pregnant individuals between 32 and 36 weeks of pregnancy to pass antibodies directly to the fetus before birth.
Dr. Maron notes that these preventative measures give infants an essential shield when they are most vulnerable. Healthcare providers evaluate each infant’s birth history and maternal antibody status to determine the most appropriate protective pathway.
Frequently Asked Questions
What is the difference between an RSV vaccine and an RSV antibody shot?
An RSV vaccine stimulates the body to produce its own antibodies over several weeks. An RSV antibody shot, or monoclonal antibody, introduces pre-formed antibodies directly into the infant’s system for immediate protection.
Are there side effects associated with RSV immunizations for infants?
Common side effects include mild redness, swelling, or pain at the injection site, and occasionally a low-grade fever. Severe allergic reactions are rare.
Parents should consult their pediatrician to discuss the timing and availability of RSV protection options for their newborns ahead of peak infection months.
Keep reading